Cibus Inc. (CBUS)
NASDAQ: CBUS
· Real-Time Price · USD
1.41
-0.06 (-4.08%)
At close: Aug 15, 2025, 3:59 PM
1.41
0.36%
After-hours: Aug 15, 2025, 05:45 PM EDT
Company Description
Cibus, Inc., a agricultural technology company, develops and licenses plant traits to seed companies for royalties.
The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.
The company is based in San Diego, California.
Cibus Inc.

Country | United States |
IPO Date | Jul 20, 2017 |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 157 |
CEO | Peter R. Beetham |
Contact Details
Address: 6455 Nancy Ridge Drive San Diego, California United States | |
Website | https://www.cibus.com |
Stock Details
Ticker Symbol | CBUS |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001705843 |
CUSIP Number | 17166A101 |
ISIN Number | US17166A1016 |
Employer ID | 27-1967997 |
SIC Code | 2870 |
Key Executives
Name | Position |
---|---|
Dr. Peter R. Beetham B.Sc., Ph.D. | Co-Founder, Interim Chief Executive Officer, President, Chief Operating Officer & Director |
Sean O'Connor Ph.D. | Senior Vice President and President & Chief Executive Officer of Nucelis |
Cornelis Broos M.Sc. | Interim Chief Financial Officer |
Jason Stokes J.D. | Chief Legal Officer, General Counsel & Corporate Secretary |
Dr. Gregory F. Gocal Ph.D. | Co-Founder, Chief Scientific Officer & Executive Vice President |
Dr. James Radtke Ph.D. | Senior Vice President of Product Development |
Noel Sauer Ph.D. | Senior Vice President of Research |
Rory Balfour Riggs M.B.A. | Co-Founder & Chairman |
Rosa Cheuk Kim J.D. | Senior Vice President of Legal |
Tony Moran | Senior Vice President of International Development |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Aug 14, 2025 | SCHEDULE 13G/A | [Amend] Filing |
Aug 14, 2025 | 10-Q | Quarterly Report |
Aug 14, 2025 | 8-K | Current Report |
Jul 23, 2025 | 8-K | Current Report |
Jun 11, 2025 | 4 | Filing |
Jun 10, 2025 | 4 | Filing |
Jun 10, 2025 | SCHEDULE 13D/A | [Amend] Filing |
Jun 06, 2025 | 8-K | Current Report |
Jun 06, 2025 | 424B5 | Filing |
Jun 04, 2025 | 8-K | Current Report |